Lempo employs a collaborative work model for its therapeutic programmes, working with clinicians and researchers at leading academic centres. Prof. Ben-Zion Garty, co-founder of Lempo and a renowned immunologist, explained, “Lempo works with carefully chosen research labs, led by worldwide experts in specific aspects of our program, covering CRISPR, HSCT, MPO deficiency, AAGN and PAH. Jointly, we are able to accelerate the program towards an optimal treatment”.
The operation is managed by a team of experienced professionals directing the distributed programmes. This model ensures high quality, fast pace and capital efficiency.
Oren Glanz - CEO
20+ years as serial entrepreneur, and CEO, founded 8 companies and sold 2
Senior lecturer at the Israeli
Recognized in 2012 as 1 of 100 most influential people in Israel
Anat Kahana, PhD - CSO
The inventor of Lempo MPO-001
Molecular Biologist – Tel Aviv
University, Bar-Ilan university and Weizmann institute of Science
Translational Medical Researcher
Prof. Ben-Zion Garty, MD
MD Pediatric Immunology
Clinician - Allergies and
Former head of children ward in Schneider Children Hospital
First physician in Israel to treat pediatric PAH
Full Professor at the Tel Aviv University medical school
Prof. Donald B. Kohn, MD
Department of Microbiology, Immunology & Molecular Genetics University of California, Los Angele.
Broad Stem Cell Research Center, UCLA
Expertise: Gene Editing, Stem cells therapies, bone marrow transplant
Prof. Stephan Rosenkranz, MD
Head of the Pulmonary
Hypertension (PH) Center at the University of Cologne,
Germany, and Cologne
Research Center (CCRC)
Expertise: Pulmonary Arterial Hypertension, MPO in CVD
Prof. Daniel Offen, PhD
Head of Translational
Neuroscience Lab, Dept. of
Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience, Tel Aviv University.
Neurological diseases and
Prof. William M. Nauseef,
Inflammation program, Iowa
University Center for
Immunology and Immune-
Expertise: MPO and MPO
Prof. David Jayne, MD, PhD
Clinical Autoimmunity, University of Cambridge
Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital.
Expertise: ANCA associated Vasculitis